Market Research Report
Thrombectomy Devices - Global Market Outlook (2016-2022)
|Published by||Stratistics Market Research Consulting||Product code||521601|
|Published||Content info||172 Pages
Delivery time: 2-3 business days
|Thrombectomy Devices - Global Market Outlook (2016-2022)|
|Published: April 1, 2017||Content info: 172 Pages||
According to Stratistics MRC, the Global Thrombectomy Devices market is estimated at $0.98 billion in 2016 and is expected to reach $1.53 billion by 2022 growing at a CAGR of 7.7% from 2016 to 2022. Rising healthcare expenditure from developing nations and increasing cardiovascular diseases in recent years are the key factors driving the market growth. Stringent government regulations imposed on devices and lack of awareness among the patients are the factors hampering the market. Whereas huge investments flow for research and development activities seem to be opportunity factor for the market.
Peripheral Vascular Applications segment is expected to move with highest CAGR during forecast period because of the favourable reimbursement policies imposed by various governments on peripheral procedures. By Product, Ultrasonic Thrombectomy Devices is expected to grow at highest CAGR during forecast period owing to the high rate of adoption by medical surgeons. Asia Pacific region is expected to show lucrative growth rate owing to technological advancements in developing economies like India, China & Indonesia and increasing demand for minimal invasive surgeries.
Some of the key players in the market include Stryker Corporation, Boston Scientific Corporation, Medtronic PLC, Terumo Corporation, Johnson & Johnson, Penumbra, Inc., Spectranetics Corporation, Teleflex Incorporated, Argon Medical Devices, Inc., Edwards Lifesciences Corporation, Straub Medical AG, BTG International, Phenox GmbH, Acandis GmbH Co. & Kg and Merit Medical Systems, Inc.